Occudo Quantitative Strategies’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
VPM
VCM
Occudo Quantitative Strategies's GH Position: Q1 2026 in Review
Occudo Quantitative Strategies increased its Guardant Health (GH) stake by 24% in Q1 2026, buying an estimated $389K and bringing the position to 20,366 shares worth $1.77M. The position accounts for 0.1% of the portfolio, ranked #286.
Occudo Quantitative Strategies first reported a position in GH in Q2 2025 and has held it in 4 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.
- Occudo Quantitative Strategies held 20,366 shares of Guardant Health worth $1.77M as of Q1 2026.
- Occudo Quantitative Strategies bought 3,878 Guardant Health shares in Q1 2026, an estimated $389K.
- Guardant Health made up 0.1% of Occudo Quantitative Strategies's portfolio in Q1 2026, its #286 holding.
- Occudo Quantitative Strategies first reported a position in Guardant Health in Q2 2025 and has held it in 4 quarters since.
- 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.
Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.